What does bluebird bio, Inc. do?
bluebird bio, Inc. is a clinical-stage biotechnology company focused on gene therapies for severe diseases and cancer, with a market cap of $48.41 million and recent net sales of $39 million. The company reported a net loss of $29 million in its latest quarterly results.
Overview:bluebird bio, Inc. is a clinical-stage biotechnology company focused on developing gene therapies for severe diseases and cancer, operating within the micro-cap market.Financial Snapshot:
- Most recent Net Sales: 39 Million (Quarterly Results - Mar 2025)
- Most recent Net Profit: -29 Million (Quarterly Results - Mar 2025)
- Market cap: USD 48.41 Million (Micro Cap)
Key Metrics:
- P/E: NA (Loss Making)
- Industry P/E: NA
- Dividend Yield: 2,008.21%
- Debt Equity: -1.22
- Return on Equity: 335.69%
- Price to Book: -0.84
Contact Details:
- Address: 60 Binney St, CAMBRIDGE MA: 02142-1512
- Tel: ['1 339 4999300', '1 410 9605022']
- Fax: 1 302 6365454
- Website: http://www.bluebirdbio.com
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
